After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Johnson & Johnson is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Johnson & Johnson is $407.97B. A total of 6.62 million shares were traded on the day, compared to an average of 8.27M shares.
In the most recent transaction, REED JOHN C sold 19,137 shares of JNJ for 163.55 per share on Jul 17 ’25. After the transaction, the EVP, Innovative Medicine, R&D now owns 10,658 company shares. In a previous transaction on Jul 17 ’25, REED JOHN C bought 19,137 shares at 163.55 per share.
Among the insiders who sold shares, Decker Robert J disposed of 6,999 shares on Feb 25 ’25 at a per-share price of $165.88. This resulted in the VP Corporate Controller holding 21,001 shares of JNJ after the transaction. In another insider transaction, Decker Robert J bought 6,999 shares at $165.88 per share on Feb 25 ’25.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Johnson & Johnson pays an annual dividend of $5.02, resulting in a dividend yield of 2.96%, and it has a price to earnings (P/E) ratio of 18.13.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, JNJ has a high of $169.99 and a low of $140.68.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $32.47, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 3.87.
